STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] 10x Genomics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

10x Genomics (TXG) Form 144 notice shows a proposed sale of 22,037 shares of common stock through Morgan Stanley Smith Barney, with an aggregate market value of $295,516.17 and an approximate sale date of 08/22/2025 on NASDAQ. The filing reports the shares were acquired as a Restricted Stock Unit grant on 08/21/2025 with 61,587 units noted as acquired and payment described as Services Rendered. It also discloses a prior sale by the same person of 4,044 shares on 05/22/2025 for gross proceeds of $33,562.37. The filer affirms no undisclosed material adverse information.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Insider plans to sell 22,037 shares (value $295.5k) from an RSU grant received one day earlier; prior small sale of 4,044 shares noted.

The filing documents a routine Rule 144 notice for the sale of common stock through a broker, indicating the shares originate from a restricted stock unit grant dated 08/21/2025 and are to be sold on 08/22/2025. The disclosure includes a recent small sale on 05/22/2025, suggesting ongoing insider liquidity activity but does not provide context on ownership percentage or company-wide impact. No financial performance data or forward-looking statements are included.

TL;DR: Filing is a standard Rule 144 notification; signer attests no undisclosed material information and references a services-based RSU payment.

The notice follows regulatory requirements by identifying the broker, share counts, acquisition method (RSU grant), and recent disposals. The signing representation about material information and the inclusion of prior sales meet disclosure norms. The document does not reveal governance changes, contracts, or material events beyond the securities transactions.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 for TXG disclose about the proposed sale?

The Form 144 discloses a proposed sale of 22,037 shares of TXG common stock valued at $295,516.17, to be sold on or about 08/22/2025 on NASDAQ through Morgan Stanley Smith Barney.

How were the shares being sold acquired according to the filing?

The shares were acquired as a Restricted Stock Unit grant on 08/21/2025; the filing lists 61,587 units acquired and indicates Services Rendered as the nature of payment.

Does the Form 144 show any recent sales by the same person?

Yes. The filing reports a prior sale of 4,044 shares on 05/22/2025 that generated gross proceeds of $33,562.37.

Which broker is handling the proposed sale listed in the Form 144?

The broker named is Morgan Stanley Smith Barney LLC Executive Services, with an address in Sandy, UT.

Does the filer attest to any undisclosed material information?

The filer signs a representation that they do not know any material adverse information regarding the issuer that has not been publicly disclosed.
10X Genomics, Inc.

NASDAQ:TXG

TXG Rankings

TXG Latest News

TXG Latest SEC Filings

TXG Stock Data

2.32B
114.34M
1.86%
104.6%
11.03%
Health Information Services
Laboratory Analytical Instruments
Link
United States
PLEASANTON